CLINDAMYCIN AND BENZOYL PEROXIDE

CLINDAMYCIN AND BENZOYL PEROXIDE was reported 272 times

CLINDAMYCIN AND BENZOYL PEROXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPLANTABLE CARDIAC MONITOR REPLACEMENT 1 0.1429
1 CONGENITAL KNEE DISLOCATION 1 0.0250
2 TRAUMATIC PAIN 1 0.0238
3 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
4 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1 0.0145
5 BLAST CELL COUNT DECREASED 1 0.0137
6 APPLICATION SITE HYPERAESTHESIA 1 0.0101
7 GENITAL DISCOMFORT 2 0.0036
8 IODINE ALLERGY 1 0.0030
9 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
10 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
11 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
12 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
13 APPLICATION SITE DISCOMFORT 4 0.0022
14 PLICATED TONGUE 1 0.0021
15 PILONIDAL CYST 1 0.0020
16 STEATOHEPATITIS 1 0.0019
17 CHEMICAL BURN 2 0.0017
18 CERVICOBRACHIAL SYNDROME 1 0.0016
19 INFUSION SITE URTICARIA 1 0.0015
20 PRECANCEROUS CONDITION 1 0.0015
21 CYST RUPTURE 1 0.0015
22 ANGULAR CHEILITIS 1 0.0014
23 PERIORBITAL PAIN 1 0.0012
24 APPLICATION SITE DRYNESS 4 0.0012
25 POUCHITIS 1 0.0012
26 APPLICATION SITE DERMATITIS 1 0.0011
27 INFUSION SITE DISCOMFORT 1 0.0010
28 PERTUSSIS 1 0.0010
29 TEETH BRITTLE 1 0.0010
30 SUPERFICIAL INJURY OF EYE 1 0.0009
31 INTRUSIVE THOUGHTS 1 0.0008
32 INFECTED CYST 1 0.0008
33 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
34 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
35 XEROSIS 1 0.0008
36 WHITE MATTER LESION 1 0.0008
37 APPLICATION SITE WARMTH 1 0.0008
38 APPLICATION SITE PAIN 17 0.0008
39 APPLICATION SITE PARAESTHESIA 1 0.0008
40 SKIN DISCOMFORT 2 0.0007
41 APPLICATION SITE DISCOLOURATION 3 0.0007
42 SIALOADENITIS 1 0.0007
43 INFUSION SITE RASH 1 0.0007
44 APPLICATION SITE RASH 10 0.0007
45 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
46 ALVEOLITIS 1 0.0007
47 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
48 SLEEP PARALYSIS 1 0.0007
49 GENITAL PAIN 1 0.0007
50 AXILLARY PAIN 1 0.0007
51 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
52 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
53 OPHTHALMOPLEGIA 1 0.0006
54 APPLICATION SITE BURN 3 0.0006
55 APPLICATION SITE SWELLING 3 0.0006
56 BLOOD CALCIUM ABNORMAL 1 0.0006
57 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
58 PRODUCT ODOUR ABNORMAL 6 0.0006
59 INFUSION SITE DISCHARGE 1 0.0006
60 NASAL OEDEMA 1 0.0006
61 HIDRADENITIS 5 0.0005
62 BLADDER SPASM 1 0.0005
63 LIP DISORDER 1 0.0005
64 APPLICATION SITE ERYTHEMA 13 0.0005
65 EYELID PAIN 1 0.0005
66 APPLICATION SITE EXFOLIATION 2 0.0005
67 SKIN INDURATION 1 0.0005
68 DEVICE CONNECTION ISSUE 1 0.0005
69 PRODUCT DISPENSING ISSUE 2 0.0005
70 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
71 APPLICATION SITE URTICARIA 1 0.0004
72 APPLICATION SITE IRRITATION 5 0.0004
73 EYELID IRRITATION 1 0.0004
74 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
75 CATHETER SITE PAIN 1 0.0004
76 PROTEIN TOTAL INCREASED 1 0.0004
77 LIP BLISTER 1 0.0004
78 STREPTOCOCCAL INFECTION 2 0.0004
79 INFUSION SITE ERYTHEMA 3 0.0004
80 PERIORBITAL SWELLING 2 0.0004
81 DEVICE POWER SOURCE ISSUE 1 0.0003
82 ACNE CYSTIC 1 0.0003
83 SWELLING OF EYELID 2 0.0003
84 INFUSION SITE PRURITUS 1 0.0003
85 BLADDER PAIN 1 0.0003
86 VULVOVAGINAL DRYNESS 1 0.0003
87 LYME DISEASE 1 0.0003
88 PLANTAR FASCIITIS 1 0.0003
89 WOUND DEHISCENCE 1 0.0003
90 SKIN WEEPING 1 0.0003
91 WOUND HAEMORRHAGE 1 0.0003
92 APPLICATION SITE PRURITUS 6 0.0003
93 GASTRIC INFECTION 1 0.0003
94 REHABILITATION THERAPY 1 0.0003
95 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
96 WOUND SECRETION 1 0.0003
97 GINGIVAL PAIN 2 0.0003
98 OESOPHAGEAL CANDIDIASIS 1 0.0003
99 FUNGAL SKIN INFECTION 1 0.0002
100 RECURRENT CANCER 1 0.0002
101 DEMYELINATION 1 0.0002
102 TONGUE DISCOMFORT 1 0.0002
103 ABSCESS LIMB 1 0.0002
104 METASTATIC NEOPLASM 1 0.0002
105 CHAPPED LIPS 1 0.0002
106 BONE CANCER 1 0.0002
107 PARONYCHIA 1 0.0002
108 URINARY TRACT DISORDER 1 0.0002
109 LIP DRY 2 0.0002
110 RENAL FUNCTION TEST ABNORMAL 1 0.0002
111 ROSACEA 1 0.0002
112 SKIN TIGHTNESS 1 0.0002
113 VAGINAL INFECTION 1 0.0002
114 EXPIRED PRODUCT ADMINISTERED 7 0.0002
115 ENDOMETRIOSIS 1 0.0002
116 SUBCUTANEOUS ABSCESS 1 0.0002
117 TUMOUR MARKER INCREASED 1 0.0002
118 ENDOCARDITIS 1 0.0002
119 NYSTAGMUS 1 0.0002
120 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
121 PRODUCT RESIDUE PRESENT 1 0.0002
122 ERYTHEMA OF EYELID 1 0.0002
123 PROSTATIC DISORDER 1 0.0002
124 INTERMENSTRUAL BLEEDING 1 0.0002
125 MACULAR OEDEMA 1 0.0002
126 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
127 DECREASED INTEREST 1 0.0002
128 PHARYNGITIS 2 0.0002
129 PRE-EXISTING CONDITION IMPROVED 1 0.0002
130 INFUSION SITE PAIN 2 0.0002
131 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
132 POLYP 1 0.0002
133 APPETITE DISORDER 1 0.0002
134 ADVERSE REACTION 2 0.0002
135 MENINGITIS 1 0.0001
136 LYMPHOEDEMA 1 0.0001
137 PAPULE 1 0.0001
138 THERMAL BURN 1 0.0001
139 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
140 IMPAIRED QUALITY OF LIFE 2 0.0001
141 FAECES SOFT 1 0.0001
142 COLON CANCER 2 0.0001
143 AORTIC ANEURYSM 1 0.0001
144 INSURANCE ISSUE 2 0.0001
145 FOOD ALLERGY 1 0.0001
146 MYASTHENIA GRAVIS 1 0.0001
147 HYPERAESTHESIA 1 0.0001
148 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
149 ACNE 9 0.0001
150 SKIN PLAQUE 1 0.0001
151 HYSTERECTOMY 1 0.0001
152 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
153 FACIAL PAIN 1 0.0001
154 RESTLESS LEGS SYNDROME 2 0.0001
155 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
156 PRODUCT DISTRIBUTION ISSUE 1 0.0001
157 EYE SWELLING 4 0.0001
158 BACTERIAL INFECTION 2 0.0001
159 HEPATIC ENCEPHALOPATHY 1 0.0001
160 PRODUCT PACKAGING ISSUE 1 0.0001
161 VITAMIN D DEFICIENCY 1 0.0001
162 SKIN FISSURES 2 0.0001
163 BLADDER DISORDER 1 0.0001
164 BURNING SENSATION 7 0.0001
165 POOR VENOUS ACCESS 1 0.0001
166 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
167 JOINT DISLOCATION 1 0.0001
168 RETCHING 2 0.0001
169 HEREDITARY ANGIOEDEMA 1 0.0001
170 SKIN LACERATION 1 0.0001
171 DENTAL CARIES 1 0.0001
172 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
173 SKIN INFECTION 1 0.0001
174 PRODUCT AVAILABILITY ISSUE 2 0.0001
175 METASTASES TO LUNG 1 0.0001
176 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
177 INJECTION SITE DISCOLOURATION 1 0.0001
178 SECRETION DISCHARGE 1 0.0001
179 INJECTION SITE IRRITATION 1 0.0001
180 ERYTHEMA 16 0.0001
181 RESPIRATORY TRACT INFECTION 2 0.0001
182 DEAFNESS 2 0.0001
183 ORAL CANDIDIASIS 1 0.0001
184 ANKYLOSING SPONDYLITIS 1 0.0001
185 SARS-COV-2 TEST POSITIVE 1 0.0001
186 EAR INFECTION 2 0.0001
187 PAIN OF SKIN 2 0.0001
188 DRUG EFFECT DECREASED 4 0.0001
189 UVEITIS 1 0.0001
190 IMPAIRED GASTRIC EMPTYING 1 0.0001
191 SKIN EXFOLIATION 6 0.0001
192 DEVICE OCCLUSION 1 0.0001
193 SKIN REACTION 1 0.0001
194 SEASONAL ALLERGY 1 0.0001
195 SKIN BURNING SENSATION 5 0.0001
196 CONDITION AGGRAVATED 21 0.0001
197 LABORATORY TEST ABNORMAL 2 0.0001
198 SKIN HAEMORRHAGE 1 0.0001
199 DRY SKIN 9 0.0001
200 ECONOMIC PROBLEM 1 0.0001
201 SKIN IRRITATION 3 0.0001
202 RASH ERYTHEMATOUS 3 0.0001
203 SCIATICA 1 0.0001
204 SWELLING FACE 4 0.0001
205 PHOTOSENSITIVITY REACTION 1 0.0001
206 FUNGAL INFECTION 2 0.0001
207 HEMIPARESIS 1 0.0001
208 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
209 SCAR 1 0.0001
210 DEVICE DEFECTIVE 1 0.0001
211 ECZEMA 3 0.0001
212 RASH MACULAR 2 0.0001
213 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
214 RASH PRURITIC 3 0.0001
215 PELVIC PAIN 1 0.0001
216 ACCIDENTAL OVERDOSE 2 0.0001
217 CONJUNCTIVITIS 1 0.0001
218 DYSTONIA 1 0.0001
219 ORAL HERPES 1 0.0001
220 ABORTION SPONTANEOUS 2 0.0000
221 PRODUCT PHYSICAL ISSUE 1 0.0000
222 PRODUCT ADMINISTRATION ERROR 1 0.0000
223 TASTE DISORDER 1 0.0000
224 RIB FRACTURE 1 0.0000
225 DERMATITIS 1 0.0000
226 KNEE ARTHROPLASTY 1 0.0000
227 MOUTH ULCERATION 1 0.0000
228 EATING DISORDER 1 0.0000
229 IMPAIRED WORK ABILITY 1 0.0000
230 IRRITABLE BOWEL SYNDROME 1 0.0000
231 LIVER FUNCTION TEST INCREASED 1 0.0000
232 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
233 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
234 TOOTH DISORDER 1 0.0000
235 GLOSSODYNIA 1 0.0000
236 RASH PAPULAR 1 0.0000
237 SNEEZING 1 0.0000
238 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
239 THROAT IRRITATION 2 0.0000
240 ASTHMA 5 0.0000
241 PRODUCT DOSE OMISSION ISSUE 13 0.0000
242 SKIN DISCOLOURATION 2 0.0000
243 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
244 MENTAL IMPAIRMENT 1 0.0000
245 NEURALGIA 1 0.0000
246 BRONCHITIS 3 0.0000
247 CELLULITIS 2 0.0000
248 PRURITUS 15 0.0000
249 EXPOSURE VIA SKIN CONTACT 1 0.0000
250 DIPLOPIA 1 0.0000
251 MUCOSAL INFLAMMATION 1 0.0000
252 SEDATION 1 0.0000
253 ANHEDONIA 1 0.0000
254 GASTRITIS 1 0.0000
255 FREQUENT BOWEL MOVEMENTS 1 0.0000
256 PNEUMONITIS 1 0.0000
257 TREATMENT NONCOMPLIANCE 2 0.0000
258 DRUG INEFFECTIVE 48 0.0000
259 ABNORMAL DREAMS 1 0.0000
260 TREATMENT FAILURE 3 0.0000
261 DIVERTICULITIS 1 0.0000
262 PROCEDURAL PAIN 1 0.0000
263 ARTHROPATHY 2 0.0000
264 FEELING COLD 1 0.0000
265 HAEMOPTYSIS 1 0.0000
266 URTICARIA 6 0.0000
267 BLISTER 2 0.0000
268 EYE PAIN 2 0.0000
269 INTENTIONAL DOSE OMISSION 1 0.0000
270 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
271 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
272 SURGERY 2 0.0000
273 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
274 CATARACT 2 0.0000
275 IRRITABILITY 2 0.0000
276 BLOOD POTASSIUM DECREASED 1 0.0000
277 LACRIMATION INCREASED 1 0.0000
278 VERTIGO 2 0.0000
279 EPILEPSY 1 0.0000
280 EXPOSURE DURING PREGNANCY 2 0.0000
281 HEAD INJURY 1 0.0000
282 RHINORRHOEA 2 0.0000
283 IMPAIRED HEALING 1 0.0000
284 STAPHYLOCOCCAL INFECTION 1 0.0000
285 LIP SWELLING 1 0.0000
286 SKIN DISORDER 1 0.0000
287 TYPE 2 DIABETES MELLITUS 1 0.0000
288 ANGER 1 0.0000
289 ILLNESS 3 0.0000
290 NEOPLASM PROGRESSION 1 0.0000
291 ABDOMINAL DISTENSION 3 0.0000
292 COVID-19 5 0.0000
293 THERAPY INTERRUPTED 2 0.0000
294 DRUG EFFECT INCOMPLETE 1 0.0000
295 RASH 12 0.0000
296 C-REACTIVE PROTEIN INCREASED 1 0.0000
297 HYPERGLYCAEMIA 1 0.0000
298 DYSURIA 1 0.0000
299 HYPERSENSITIVITY 5 0.0000
300 EPISTAXIS 2 0.0000
301 DEPRESSION 6 0.0000
302 PERIPHERAL SWELLING 4 0.0000
303 EXTRA DOSE ADMINISTERED 1 0.0000
304 PSORIATIC ARTHROPATHY 1 0.0000
305 BLINDNESS 1 0.0000
306 DEVICE LEAKAGE 1 0.0000
307 PRODUCT STORAGE ERROR 2 0.0000
308 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
309 INJECTION SITE PAIN 7 0.0000
310 GASTROINTESTINAL DISORDER 2 0.0000
311 THERAPY NON-RESPONDER 1 0.0000
312 PRODUCT QUALITY ISSUE 3 0.0000
313 SUICIDAL IDEATION 2 0.0000
314 NEPHROLITHIASIS 1 0.0000
315 HYPOKALAEMIA 1 0.0000
316 COGNITIVE DISORDER 1 0.0000
317 OCULAR HYPERAEMIA 1 0.0000
318 PRODUCTIVE COUGH 1 0.0000
319 HYPOGLYCAEMIA 1 0.0000
320 FLUID RETENTION 1 0.0000
321 CHEST DISCOMFORT 2 0.0000
322 SINUSITIS 2 0.0000
323 INFLAMMATION 1 0.0000
324 DERMATITIS ATOPIC 1 0.0000
325 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
326 OEDEMA 1 0.0000
327 ANAPHYLACTIC REACTION 1 0.0000
328 FALL 6 0.0000
329 FLATULENCE 1 0.0000
330 URINARY TRACT INFECTION 3 0.0000
331 HERPES ZOSTER 1 0.0000
332 EYE IRRITATION 1 0.0000
333 DYSPHONIA 1 0.0000
334 NASAL CONGESTION 1 0.0000
335 WHEEZING 1 0.0000
336 EMOTIONAL DISTRESS 2 0.0000
337 THERAPEUTIC RESPONSE DECREASED 1 0.0000
338 DISCOMFORT 1 0.0000
339 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
340 PAIN 10 0.0000
341 NASOPHARYNGITIS 3 0.0000
342 VISUAL IMPAIRMENT 2 0.0000
343 HEADACHE 10 0.0000
344 DEVICE EXPULSION 1 0.0000
345 BLOOD CREATININE INCREASED 1 0.0000
346 PSORIASIS 2 0.0000
347 SOMNOLENCE 3 0.0000
348 WEIGHT DECREASED 4 0.0000
349 COUGH 4 0.0000
350 INJURY 1 0.0000
351 SLEEP DISORDER 1 0.0000
352 HYPERTENSION 3 0.0000
353 MOBILITY DECREASED 1 0.0000
354 NAUSEA 11 0.0000
355 HOT FLUSH 1 0.0000
356 INCORRECT DOSE ADMINISTERED 3 0.0000
357 ARTHRITIS 1 0.0000
358 INJECTION SITE HAEMORRHAGE 1 0.0000
359 FEELING ABNORMAL 3 0.0000
360 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
361 DIARRHOEA 8 0.0000
362 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
363 ABDOMINAL DISCOMFORT 2 0.0000
364 RENAL IMPAIRMENT 1 0.0000
365 BALANCE DISORDER 1 0.0000
366 FATIGUE 9 0.0000
367 MUSCULOSKELETAL STIFFNESS 1 0.0000
368 INSOMNIA 3 0.0000
369 DEVICE ISSUE 1 0.0000
370 NO ADVERSE EVENT 2 0.0000
371 OROPHARYNGEAL PAIN 1 0.0000
372 CARDIAC DISORDER 1 0.0000
373 SWELLING 1 0.0000
374 PRODUCT USE ISSUE 2 0.0000
375 ANXIETY 3 0.0000
376 DYSPHAGIA 1 0.0000
377 NEUROPATHY PERIPHERAL 1 0.0000
378 MIGRAINE 1 0.0000
379 GAIT DISTURBANCE 2 0.0000
380 ALOPECIA 2 0.0000
381 DYSPEPSIA 1 0.0000
382 SYNCOPE 1 0.0000
383 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
384 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
385 CONSTIPATION 2 0.0000
386 INFLUENZA 1 0.0000
387 WEIGHT INCREASED 2 0.0000
388 MUSCULAR WEAKNESS 1 0.0000
389 PYREXIA 3 0.0000
390 SEIZURE 1 0.0000
391 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
392 CHILLS 1 0.0000
393 JOINT SWELLING 1 0.0000
394 OFF LABEL USE 7 0.0000
395 ASTHENIA 3 0.0000
396 RENAL FAILURE 1 0.0000
397 DEHYDRATION 1 0.0000
398 NEUTROPENIA 1 0.0000
399 ARTHRALGIA 3 0.0000
400 DYSPNOEA 4 0.0000
401 MALAISE 3 0.0000
402 PAIN IN EXTREMITY 2 0.0000
403 VOMITING 3 0.0000
404 CONFUSIONAL STATE 1 0.0000
405 PNEUMONIA 2 0.0000
406 DIZZINESS 3 0.0000
407 MYALGIA 1 0.0000
408 CHEST PAIN 1 0.0000
409 ANAEMIA 1 0.0000
410 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
411 OVERDOSE 1 0.0000
412 BACK PAIN 1 0.0000
413 ABDOMINAL PAIN 1 0.0000
414 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000